+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Angelini Pharma SpA - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 29 Pages
  • February 2025
  • GlobalData
  • ID: 1816436
Angelini Pharma SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Angelini Pharma Spa (Angelini Pharma) manufactures, markets and commercializes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with a focus on pain and inflammation disorders, traveler's diarrhea, infection control and infectious diseases, bacterial infections, mental health, and central nervous system diseases and disorders. Its products include benzydamine, trazodone, paracetamol, progesterone, glycerin, tetrahydrozoline, lactitol and prulifloxacin, among others. The company offers its products through brands such as Andolex, Trittico, Aulin, Tachipirina, Tantum, Lono, Vantal to Hospitals, Research Centers, Pharma Biotech and Contract Research Organizations. It operates manufacturing facilities in Italy, Spain and the US. Angelini Pharma is headquartered in Rome, Italy.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Angelini Pharma SpA - Key Facts
  • Angelini Pharma SpA - Key Employees
  • Angelini Pharma SpA - Key Employee Biographies
  • Angelini Pharma SpA - Major Products and Services
  • Angelini Pharma SpA - History
  • Angelini Pharma SpA - Company Statement
  • Angelini Pharma SpA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Angelini Pharma SpA - Business Description
  • R&D Overview
  • Angelini Pharma SpA - SWOT Analysis
  • SWOT Analysis - Overview
  • Angelini Pharma SpA - Strengths
  • Angelini Pharma SpA - Weaknesses
  • Angelini Pharma SpA - Opportunities
  • Angelini Pharma SpA - Threats
  • Angelini Pharma SpA - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Angelini Pharma SpA, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Angelini Pharma SpA, Key Facts
  • Angelini Pharma SpA, Key Employees
  • Angelini Pharma SpA, Key Employee Biographies
  • Angelini Pharma SpA, Major Products and Services
  • Angelini Pharma SpA, History
  • Angelini Pharma SpA, Subsidiaries
  • Angelini Pharma SpA, Joint Venture
  • Angelini Pharma SpA, Key Competitors
  • Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Angelini Pharma SpA, Recent Deals Summary
List of Figures
  • Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Shedir Pharma Srl
  • Biocure SRL
  • Newron Pharmaceuticals SpA
  • Chiesi Farmaceutici SpA
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Dompe Farmaceutici SpA
  • Alfasigma SpA
  • Fabbrica Italiana Sintetici SpA